atai Life Sciences N.V. (ATAI) — atai priced an underwritten offering of common shares at $5.48 each, drawing new institutional investors including Janus Henderson, Foresite Capital, Deep Track Capital and HBM Partners alongside existing backers.
With the underwriters' option exercised, the deal totaled about 27.3 million shares for approximately $149.5 million in gross proceeds. The capital bolsters atai's balance sheet ahead of its Beckley Psytech merger and Phase 3 plans.
Source: theglobeandmail.com
For the rest of that week's sector news, read our week in review.